NASDAQ:MATK
$31.49
- 0.01
Feb 25, 2011
4:00 PM ET
Martek Biosciences Corporation
Investors
Home
About Martek
Healthcare Professionals
Investors
Press Releases
Events & Presentations
Management
Financial Information
SEC Filings
Quarterly Results
Annual Reports & Proxy
Investor FAQs
Products & Services
Home
Investors
Financial Information
Financial Information
Here you will find a summary of Martek Biosciences Corporation's latest financial information.
Latest Earnings Release and 10-Q
Date Filed
Format
Size
Fourth Quarter Financial Results
N/A
Latest Annual Report and 10-K
Date Filed
Format
Size
2010 Form 10-K/A
Feb 25, 2011
375.3 KB